rs138880727
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The ENST00000395503.9(ATP2A1):c.1370C>T(p.Thr457Met) variant causes a missense change. The variant allele was found at a frequency of 0.000174 in 1,612,480 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T457A) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000395503.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP2A1 | NM_004320.6 | c.1370C>T | p.Thr457Met | missense_variant | 12/23 | ENST00000395503.9 | NP_004311.1 | |
ATP2A1 | NM_173201.5 | c.1370C>T | p.Thr457Met | missense_variant | 12/22 | NP_775293.1 | ||
ATP2A1 | NM_001286075.2 | c.995C>T | p.Thr332Met | missense_variant | 10/21 | NP_001273004.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP2A1 | ENST00000395503.9 | c.1370C>T | p.Thr457Met | missense_variant | 12/23 | 1 | NM_004320.6 | ENSP00000378879 | P4 | |
ATP2A1 | ENST00000357084.7 | c.1370C>T | p.Thr457Met | missense_variant | 12/22 | 2 | ENSP00000349595 | A1 | ||
ATP2A1 | ENST00000536376.5 | c.995C>T | p.Thr332Met | missense_variant | 10/21 | 2 | ENSP00000443101 | |||
ATP2A1 | ENST00000564732.1 | c.*13C>T | 3_prime_UTR_variant, NMD_transcript_variant | 4/7 | 5 | ENSP00000457357 |
Frequencies
GnomAD3 genomes AF: 0.000828 AC: 126AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000176 AC: 44AN: 249646Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 135100
GnomAD4 exome AF: 0.000105 AC: 154AN: 1460262Hom.: 0 Cov.: 34 AF XY: 0.000100 AC XY: 73AN XY: 726464
GnomAD4 genome AF: 0.000828 AC: 126AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.000900 AC XY: 67AN XY: 74412
ClinVar
Submissions by phenotype
Brody myopathy Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 15, 2022 | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 457 of the ATP2A1 protein (p.Thr457Met). This variant is present in population databases (rs138880727, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with ATP2A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 392455). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 03, 2023 | - - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 17, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 24, 2021 | Missense variants in this gene are often considered pathogenic (Stenson et al., 2014); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at